HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

André J Scheen Selected Research

Metformin (Glucophage)

1/2021Could metformin modulate cardiovascular outcomes differently with DPP-4 inhibitors compared with SGLT2 inhibitors?
10/2020Sodium-glucose cotransporter type 2 inhibitors for the treatment of type 2 diabetes mellitus.
1/2020SGLT2 Inhibitors as Add-On Therapy to Metformin for People with Type 2 Diabetes: A Review of Placebo-Controlled Trials in Asian versus Non-Asian Patients.
1/2020Series: Implications of the recent CVOTs in type 2 diabetes: Impact on guidelines: The endocrinologist point of view.
1/2019Why not adding a glucose-lowering agent with proven cardioprotection in high-risk patients with type 2 diabetes at HbA1c target on metformin?
1/2019An update on the safety of SGLT2 inhibitors.
8/2018The safety of empagliflozin plus metformin for the treatment of type 2 diabetes.
8/2017[DPP-4 or SGLT2 inhibitor added to metformin alone in type 2 diabetes].
8/2017[Therapeutic options for a type 2 diabetic patient not well controlled with metformin plus basal insulin].
10/2016SGLT2 Inhibitors: Benefit/Risk Balance.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


André J Scheen Research Topics

Disease

106Type 2 Diabetes Mellitus (MODY)
01/2022 - 03/2002
19Insulin Resistance
03/2015 - 03/2002
18Heart Failure
01/2022 - 01/2004
17Cardiovascular Diseases (Cardiovascular Disease)
11/2021 - 12/2007
16Weight Loss (Weight Reduction)
08/2021 - 04/2005
14Body Weight (Weight, Body)
01/2020 - 09/2003
12Hypoglycemia (Reactive Hypoglycemia)
01/2019 - 10/2010
11Weight Gain
01/2020 - 01/2004
9Overweight
01/2022 - 04/2005
9Chronic Renal Insufficiency
01/2022 - 01/2008
8Obesity
08/2021 - 04/2005
8Hyperglycemia
01/2020 - 06/2012
8Hypertension (High Blood Pressure)
01/2018 - 09/2003
7Infections
11/2021 - 04/2015
6Acute Kidney Injury (Acute Renal Failure)
03/2022 - 01/2015
6Myocardial Infarction
05/2017 - 01/2004
5Diabetes Mellitus
01/2022 - 12/2006
5Neoplasms (Cancer)
01/2022 - 09/2010
5Nausea
01/2017 - 11/2006
5Abdominal Obesity
02/2009 - 12/2007
4Albuminuria
01/2022 - 07/2013
4Diabetic Nephropathies (Diabetic Nephropathy)
03/2020 - 01/2015
4Renal Insufficiency (Renal Failure)
08/2017 - 01/2008
4Metabolic Syndrome (Dysmetabolic Syndrome X)
03/2015 - 09/2003
4Mood Disorders (Mood Disorder)
02/2009 - 11/2006
3COVID-19
11/2021 - 05/2020
3Dizziness (Lightheadedness)
02/2009 - 11/2006
3Glucose Intolerance
02/2009 - 01/2003
2Frailty
03/2022 - 08/2017
2Hypotension (Low Blood Pressure)
11/2021 - 08/2017
2Chronic Kidney Failure (Chronic Renal Failure)
08/2021 - 01/2019
2Kidney Diseases (Kidney Disease)
10/2020 - 08/2020
2Dehydration (Water Stress)
08/2017 - 01/2015
2Stroke (Strokes)
08/2017 - 11/2012
2Liver Diseases (Liver Disease)
04/2015 - 09/2014
2Inflammation (Inflammations)
03/2015 - 11/2014
2Fibrosis (Cirrhosis)
09/2014 - 06/2014
2Lactic Acidosis
05/2013 - 03/2012
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
09/2010 - 01/2007

Drug/Important Bio-Agent (IBA)

47Glucose (Dextrose)FDA LinkGeneric
03/2022 - 03/2002
34Metformin (Glucophage)FDA LinkGeneric
01/2021 - 09/2003
27Sodium-Glucose Transporter 2 InhibitorsIBA
03/2022 - 04/2014
25Sodium-Glucose Transport ProteinsIBA
03/2022 - 04/2014
25Insulin (Novolin)FDA Link
12/2017 - 03/2002
15Dipeptidyl-Peptidase IV InhibitorsIBA
11/2021 - 10/2010
14Pharmaceutical PreparationsIBA
01/2022 - 09/2003
13Glucagon-Like Peptide-1 Receptor AgonistsIBA
08/2021 - 03/2012
11empagliflozinIBA
10/2020 - 03/2014
10IncretinsIBA
08/2021 - 04/2010
9saxagliptinFDA Link
11/2018 - 10/2010
9RimonabantIBA
02/2009 - 04/2005
7Triglycerides (Triacylglycerol)IBA
09/2010 - 04/2005
7HDL CholesterolIBA
09/2010 - 04/2005
6Hypoglycemic Agents (Hypoglycemics)IBA
11/2021 - 03/2002
6Glucagon-Like Peptide-1 ReceptorIBA
11/2019 - 08/2014
6Sitagliptin Phosphate (Januvia)FDA Link
11/2018 - 10/2010
6ThiazolidinedionesIBA
09/2010 - 03/2002
5SodiumIBA
01/2022 - 03/2014
5Glucagon-Like Peptide 1 (GLP 1)IBA
08/2021 - 03/2012
5CanagliflozinIBA
10/2020 - 08/2017
5dapagliflozinIBA
10/2020 - 05/2017
5AdiponectinIBA
02/2009 - 12/2007
4Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
11/2021 - 04/2006
4LiraglutideFDA Link
08/2021 - 05/2017
4Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
01/2020 - 02/2009
4LipidsIBA
08/2016 - 01/2004
4EndocannabinoidsIBA
02/2009 - 12/2007
4CannabinoidsIBA
02/2009 - 11/2006
3SymportersIBA
01/2022 - 03/2014
3semaglutideIBA
08/2021 - 09/2018
3alogliptinIBA
11/2018 - 05/2013
3Antihypertensive Agents (Antihypertensives)IBA
01/2018 - 01/2004
3Pioglitazone (Actos)FDA Link
06/2015 - 01/2004
3LinagliptinIBA
05/2013 - 12/2011
3Rosiglitazone (Avandia)FDA Link
11/2012 - 01/2004
3CB1 Cannabinoid Receptor (CB1 Receptor)IBA
02/2009 - 04/2005
3C-Reactive ProteinIBA
02/2009 - 12/2007
2DiureticsIBA
01/2022 - 01/2004
2Hormones (Hormone)IBA
08/2021 - 11/2014
2Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA
01/2021 - 02/2013
2EnzymesIBA
01/2021 - 09/2010
2ThiazidesIBA
01/2018 - 01/2004
2Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA
01/2018 - 01/2004
2Glucagon (Glukagon)FDA Link
12/2017 - 03/2002
2TabletsIBA
12/2017 - 01/2004
2dulaglutideIBA
01/2017 - 01/2016
2Proteins (Proteins, Gene)FDA Link
01/2016 - 05/2015
2brivaracetamIBA
01/2016 - 05/2015
2LigandsIBA
01/2016 - 05/2015
2InflammasomesIBA
08/2014 - 11/2013
2CreatinineIBA
05/2013 - 01/2008
2LDL CholesterolIBA
06/2012 - 02/2009
2HDL LipoproteinsIBA
02/2009 - 12/2007
2AcarboseFDA LinkGeneric
01/2003 - 11/2002

Therapy/Procedure

42Therapeutics
01/2022 - 03/2002
5Drug Therapy (Chemotherapy)
04/2017 - 03/2008
4Surgical Amputation (Amputations)
11/2021 - 08/2017
3Injections
08/2017 - 01/2007
3Glycemic Control
03/2013 - 10/2010
2Drug Tapering
01/2020 - 08/2016